Table 3. Anti-TB therapy and diseases related characteristics of TB patients, North Gondar zone, Northwest Ethiopia, May 2013.
| Characteristics | Frequency | Percent | |
| Experience of side effects | Yes | 109 | 38.9 |
| No | 171 | 61.1 | |
| Types of side effects (n = 109) | Skin rash | 17 | 15.6 |
| Headache & dizziness | 42 | 36.7 | |
| Yellow eyes | 13 | 11.9 | |
| Vomiting | 32 | 29.4 | |
| Urine discoloration | 82 | 75.2 | |
| Symptoms of TB during the interview | Yes | 36 | 12.9 |
| No | 244 | 87.1 | |
| Treatment category | New | 245 | 87.5 |
| Re-treatment | 35 | 12.5 | |
| Types of TB | PTB-SM+ | 116 | 41.4 |
| PTB-SM− | 97 | 34.7 | |
| EPTB | 67 | 23.9 | |
| HIV screening status | Screened | 273 | 97.5 |
| Not screened | 7 | 2.5 | |
| HIV status (n = 273) | Positive | 64 | 23.4 |
| Negative | 209 | 76.6 | |
| ART status (n = 64) | Started | 44 | 68.8 |
| Not started | 20 | 31.2 | |
| OIs other than TB (n = 64) | Yes | 17 | 26.6 |
| No | 47 | 73.4 | |
| Drugs other than anti-TB & HAART (n) | None | 221 | 93.6 |
| CPT | 15 | 6.4 | |
| Phases of chemotherapy | Intensive phase | 86 | 30.7 |
| Continuation phase | 194 | 69.3 |
CPT = cotrimoxazole preventive therapy, EPTB = Extra pulmonary TB, PTB-SM+ = Smear positive pulmonary TB, PTB-SM− = Smear negative pulmonary TB, OI = Opportunistic Infections.